Nanotechnology has made significant strides in recent years, and one of the most promising applications is the use of nanorobots for precision medicine. A recent study led by Professor Feifei Wang from the University of Hong Kong presents an innovative method for tracking these nanorobots in real-time, thus enhancing their ability to deliver drugs directly to targeted tissues within the body's environment.

Tracking Nanorobots with Near-Infrared II Imaging

The challenge in utilizing nanorobots for drug delivery lies primarily in navigating and monitoring them as they move through complex physiological environments. Conventional imaging methods often produce blurred images due to light scattering and require lengthy exposure times, limiting their practical application in real-time scenarios.

To address these issues, the research team developed a near-infrared II (NIR-II) fluorescence vision platform operating in the wavelength range of 1,000 to 3,000 nm. This platform facilitates clearer imaging by reducing light scattering and minimizing the interference caused by tissue autofluorescence. As stated by Professor Wang, “NIR-II offers superior contrast, resolution, and penetration depth.”

Key Features of the NIR-II Imaging Platform

  • High Sensitivity: Enhanced visibility of nanorobots through improved imaging systems.
  • Real-Time Navigation: Provides immediate feedback for guiding the movement of nanorobots.
  • Simultaneous Visualization: Allows for concurrent observation of nanorobots and their target locations, facilitating accurate drug delivery.

Performance in Live Models

In preclinical trials using live mouse models, the team demonstrated the capability of NIR-II magnetic nanorobots to achieve precise locomotion across several organs, including:

Organ Functionality Observed
Gastrointestinal Tract Targeted treatment for inflammatory bowel disease.
Peritoneal Cavity Effective drug delivery and agent localization.
Hindlimb Demonstrated rapid and accurate navigation.
Liver Potential for localized therapies against hepatic conditions.
Spleen Enhanced targeting capabilities for immunotherapy.

The results showed a marked improvement in delivery efficiency, achieving approximately 30% higher delivery rates compared to previous methods, while enabling locomotion speeds more than 100 times faster.

Implications for Precision Medicine

The advancements offered by NIR-II nanorobot technology herald a new era in precise, image-guided drug delivery systems. Its potential applications extend beyond inflammatory diseases, encompassing:

  • Targeted Cancer Therapy: Where precise localization of the drug is crucial.
  • Neurological Disorders: Where delivery must navigate complex brain structures.
  • Autoimmune Diseases: For focused treatment regimens.

The introduction of such an innovative imaging platform exemplifies the intersection of nanotechnology and medical science, paving a path toward improved therapeutic strategies.

“The ability to accurately guide nanorobots in vivo could transform how conditions are treated, leading to high specificity and reduced side effects,” said Dr. Zideng Dai, first author of the study.

Conclusion

The development of this real-time NIR-II imaging platform not only addresses previous challenges faced in tracking nanorobots but also opens new avenues for their application in various medical fields. As researchers continue to explore enhancements in nanorobot functionality, further innovations are anticipated, promising tailored therapies that could meet the dynamic needs of patients.

References

[1] Zideng Dai et al, Real-time near-infrared II fluorescence navigation of magnetic nanorobots for image-guided therapy, _Science Advances_ (2026). DOI: 10.1126/sciadv.aea5126

[2] Science X (2026, June 20) Infrared navigation lets magnetic nanorobots deliver drugs with real-time precision tracking. Retrieved from Science X.